nodes	percent_of_prediction	percent_of_DWPC	metapath
Dutasteride—CYP3A5—Temsirolimus—kidney cancer	0.179	0.22	CbGbCtD
Dutasteride—CYP3A4—Everolimus—kidney cancer	0.103	0.127	CbGbCtD
Dutasteride—CYP3A4—Temsirolimus—kidney cancer	0.0698	0.0859	CbGbCtD
Dutasteride—CYP3A5—Erlotinib—kidney cancer	0.0671	0.0826	CbGbCtD
Dutasteride—CYP3A5—Paclitaxel—kidney cancer	0.0614	0.0756	CbGbCtD
Dutasteride—CYP3A5—Sorafenib—kidney cancer	0.0545	0.0672	CbGbCtD
Dutasteride—CYP3A5—Vincristine—kidney cancer	0.0529	0.0652	CbGbCtD
Dutasteride—CYP3A5—Sunitinib—kidney cancer	0.0442	0.0544	CbGbCtD
Dutasteride—CYP3A4—Pazopanib—kidney cancer	0.0367	0.0451	CbGbCtD
Dutasteride—CYP3A4—Erlotinib—kidney cancer	0.0262	0.0322	CbGbCtD
Dutasteride—CYP3A4—Paclitaxel—kidney cancer	0.0239	0.0295	CbGbCtD
Dutasteride—CYP3A4—Sorafenib—kidney cancer	0.0213	0.0262	CbGbCtD
Dutasteride—CYP3A4—Vinblastine—kidney cancer	0.021	0.0259	CbGbCtD
Dutasteride—CYP3A4—Vincristine—kidney cancer	0.0206	0.0254	CbGbCtD
Dutasteride—CYP3A4—Sunitinib—kidney cancer	0.0172	0.0212	CbGbCtD
Dutasteride—CYP3A4—Doxorubicin—kidney cancer	0.0129	0.0159	CbGbCtD
Dutasteride—Localised oedema—Pazopanib—kidney cancer	0.0106	0.0839	CcSEcCtD
Dutasteride—Breast cancer—Everolimus—kidney cancer	0.00578	0.0458	CcSEcCtD
Dutasteride—Localised oedema—Paclitaxel—kidney cancer	0.00468	0.0372	CcSEcCtD
Dutasteride—SRD5A1—Androgen biosynthesis—POMC—kidney cancer	0.00462	0.0797	CbGpPWpGaD
Dutasteride—SRD5A2—Androgen biosynthesis—POMC—kidney cancer	0.00462	0.0797	CbGpPWpGaD
Dutasteride—Breast cancer—Gemcitabine—kidney cancer	0.00387	0.0307	CcSEcCtD
Dutasteride—Localised oedema—Capecitabine—kidney cancer	0.00384	0.0305	CcSEcCtD
Dutasteride—Neoplasm malignant—Pazopanib—kidney cancer	0.00313	0.0248	CcSEcCtD
Dutasteride—CYP3A5—Aflatoxin activation and detoxification—ACY1—kidney cancer	0.00281	0.0484	CbGpPWpGaD
Dutasteride—Tenderness—Erlotinib—kidney cancer	0.00233	0.0185	CcSEcCtD
Dutasteride—Hyperaesthesia—Sunitinib—kidney cancer	0.00224	0.0178	CcSEcCtD
Dutasteride—Depressed mood—Capecitabine—kidney cancer	0.00217	0.0172	CcSEcCtD
Dutasteride—Neoplasm malignant—Sorafenib—kidney cancer	0.00214	0.017	CcSEcCtD
Dutasteride—Neoplasm malignant—Sunitinib—kidney cancer	0.00206	0.0164	CcSEcCtD
Dutasteride—Cardiac failure—Pazopanib—kidney cancer	0.00199	0.0158	CcSEcCtD
Dutasteride—SRD5A2—Metabolism of steroid hormones and vitamin D—POMC—kidney cancer	0.00192	0.0331	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of steroid hormones and vitamin D—POMC—kidney cancer	0.00192	0.0331	CbGpPWpGaD
Dutasteride—Neoplasm—Vinblastine—kidney cancer	0.00191	0.0152	CcSEcCtD
Dutasteride—Neoplasm—Everolimus—kidney cancer	0.00191	0.0151	CcSEcCtD
Dutasteride—Breast disorder—Pazopanib—kidney cancer	0.00175	0.0139	CcSEcCtD
Dutasteride—Neoplasm malignant—Gemcitabine—kidney cancer	0.00165	0.0131	CcSEcCtD
Dutasteride—Neoplasm—Sorafenib—kidney cancer	0.00165	0.0131	CcSEcCtD
Dutasteride—Gynaecomastia—Sorafenib—kidney cancer	0.00164	0.013	CcSEcCtD
Dutasteride—Tenderness—Gemcitabine—kidney cancer	0.00162	0.0128	CcSEcCtD
Dutasteride—Neoplasm—Sunitinib—kidney cancer	0.00159	0.0126	CcSEcCtD
Dutasteride—Cardiac failure—Everolimus—kidney cancer	0.00157	0.0124	CcSEcCtD
Dutasteride—Hyperaesthesia—Paclitaxel—kidney cancer	0.00151	0.012	CcSEcCtD
Dutasteride—Breast disorder—Everolimus—kidney cancer	0.00138	0.011	CcSEcCtD
Dutasteride—Cardiac failure—Sorafenib—kidney cancer	0.00136	0.0108	CcSEcCtD
Dutasteride—Tenderness—Paclitaxel—kidney cancer	0.00136	0.0108	CcSEcCtD
Dutasteride—Breast pain—Paclitaxel—kidney cancer	0.00136	0.0108	CcSEcCtD
Dutasteride—Cardiac failure—Sunitinib—kidney cancer	0.00131	0.0104	CcSEcCtD
Dutasteride—CYP3A4—Aflatoxin activation and detoxification—ACY1—kidney cancer	0.00131	0.0225	CbGpPWpGaD
Dutasteride—Immune system disorder—Temsirolimus—kidney cancer	0.00129	0.0102	CcSEcCtD
Dutasteride—Mental disorder—Temsirolimus—kidney cancer	0.00125	0.00989	CcSEcCtD
Dutasteride—Hyperaesthesia—Capecitabine—kidney cancer	0.00124	0.00981	CcSEcCtD
Dutasteride—Erectile dysfunction—Everolimus—kidney cancer	0.00122	0.00966	CcSEcCtD
Dutasteride—Breast disorder—Sorafenib—kidney cancer	0.0012	0.00952	CcSEcCtD
Dutasteride—Mental disorder—Pazopanib—kidney cancer	0.00117	0.00932	CcSEcCtD
Dutasteride—SRD5A1—renal system—kidney cancer	0.00114	0.283	CbGeAlD
Dutasteride—Angioedema—Temsirolimus—kidney cancer	0.00113	0.00898	CcSEcCtD
Dutasteride—Neoplasm—Paclitaxel—kidney cancer	0.00107	0.00849	CcSEcCtD
Dutasteride—Erectile dysfunction—Sorafenib—kidney cancer	0.00106	0.00839	CcSEcCtD
Dutasteride—Cardiac failure—Gemcitabine—kidney cancer	0.00105	0.00834	CcSEcCtD
Dutasteride—SRD5A1—gonad—kidney cancer	0.00102	0.254	CbGeAlD
Dutasteride—CYP3A5—Irinotecan Pathway—BCHE—kidney cancer	0.00101	0.0173	CbGpPWpGaD
Dutasteride—Immune system disorder—Everolimus—kidney cancer	0.000956	0.00759	CcSEcCtD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.000941	0.0162	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.000941	0.0162	CbGpPWpGaD
Dutasteride—Mental disorder—Everolimus—kidney cancer	0.000927	0.00736	CcSEcCtD
Dutasteride—Mental disorder—Erlotinib—kidney cancer	0.000895	0.0071	CcSEcCtD
Dutasteride—Cardiac failure—Paclitaxel—kidney cancer	0.00088	0.00698	CcSEcCtD
Dutasteride—Neoplasm—Capecitabine—kidney cancer	0.000878	0.00696	CcSEcCtD
Dutasteride—Erectile dysfunction—Vincristine—kidney cancer	0.000861	0.00683	CcSEcCtD
Dutasteride—Angioedema—Everolimus—kidney cancer	0.000842	0.00668	CcSEcCtD
Dutasteride—Immune system disorder—Sorafenib—kidney cancer	0.00083	0.00659	CcSEcCtD
Dutasteride—CYP3A4—Fatty Acid Omega Oxidation—ALDH1A1—kidney cancer	0.000821	0.0141	CbGpPWpGaD
Dutasteride—Mental disorder—Sorafenib—kidney cancer	0.000805	0.00639	CcSEcCtD
Dutasteride—Immune system disorder—Sunitinib—kidney cancer	0.000799	0.00634	CcSEcCtD
Dutasteride—Hyperaesthesia—Doxorubicin—kidney cancer	0.000797	0.00633	CcSEcCtD
Dutasteride—Breast disorder—Paclitaxel—kidney cancer	0.000776	0.00616	CcSEcCtD
Dutasteride—Mental disorder—Sunitinib—kidney cancer	0.000775	0.00615	CcSEcCtD
Dutasteride—Libido decreased—Capecitabine—kidney cancer	0.00076	0.00603	CcSEcCtD
Dutasteride—Hypersensitivity—Temsirolimus—kidney cancer	0.000745	0.00591	CcSEcCtD
Dutasteride—Neoplasm malignant—Doxorubicin—kidney cancer	0.000733	0.00581	CcSEcCtD
Dutasteride—Angioedema—Sorafenib—kidney cancer	0.000731	0.0058	CcSEcCtD
Dutasteride—Cardiac failure—Capecitabine—kidney cancer	0.000722	0.00573	CcSEcCtD
Dutasteride—Breast pain—Doxorubicin—kidney cancer	0.000717	0.00569	CcSEcCtD
Dutasteride—Pruritus—Temsirolimus—kidney cancer	0.000715	0.00568	CcSEcCtD
Dutasteride—Angioedema—Sunitinib—kidney cancer	0.000703	0.00558	CcSEcCtD
Dutasteride—Disturbance in sexual arousal—Capecitabine—kidney cancer	0.000699	0.00555	CcSEcCtD
Dutasteride—Pruritus—Pazopanib—kidney cancer	0.000674	0.00535	CcSEcCtD
Dutasteride—Dizziness—Temsirolimus—kidney cancer	0.000669	0.0053	CcSEcCtD
Dutasteride—CYP3A4—urine—kidney cancer	0.000667	0.166	CbGeAlD
Dutasteride—Mental disorder—Vincristine—kidney cancer	0.000655	0.0052	CcSEcCtD
Dutasteride—Immune system disorder—Gemcitabine—kidney cancer	0.000641	0.00508	CcSEcCtD
Dutasteride—Rash—Temsirolimus—kidney cancer	0.000637	0.00506	CcSEcCtD
Dutasteride—Dermatitis—Temsirolimus—kidney cancer	0.000637	0.00505	CcSEcCtD
Dutasteride—Breast disorder—Capecitabine—kidney cancer	0.000637	0.00505	CcSEcCtD
Dutasteride—Dizziness—Pazopanib—kidney cancer	0.00063	0.005	CcSEcCtD
Dutasteride—SRD5A2—Metabolism—ACY1—kidney cancer	0.000605	0.0104	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—ACY1—kidney cancer	0.000605	0.0104	CbGpPWpGaD
Dutasteride—Rash—Pazopanib—kidney cancer	0.000601	0.00477	CcSEcCtD
Dutasteride—Dermatitis—Pazopanib—kidney cancer	0.0006	0.00476	CcSEcCtD
Dutasteride—CYP3A4—Aflatoxin B1 metabolism—GSTM1—kidney cancer	0.000595	0.0103	CbGpPWpGaD
Dutasteride—Neoplasm—Doxorubicin—kidney cancer	0.000566	0.00449	CcSEcCtD
Dutasteride—Hypersensitivity—Vinblastine—kidney cancer	0.000556	0.00441	CcSEcCtD
Dutasteride—Hypersensitivity—Everolimus—kidney cancer	0.000554	0.0044	CcSEcCtD
Dutasteride—CYP3A4—Codeine and Morphine Metabolism—ABCB1—kidney cancer	0.000551	0.0095	CbGpPWpGaD
Dutasteride—CYP3A5—Irinotecan Pathway—APC—kidney cancer	0.000546	0.00941	CbGpPWpGaD
Dutasteride—Immune system disorder—Paclitaxel—kidney cancer	0.000537	0.00426	CcSEcCtD
Dutasteride—Pruritus—Everolimus—kidney cancer	0.000532	0.00422	CcSEcCtD
Dutasteride—CYP3A5—Xenobiotics—CYP1A1—kidney cancer	0.000524	0.00903	CbGpPWpGaD
Dutasteride—Mental disorder—Paclitaxel—kidney cancer	0.00052	0.00413	CcSEcCtD
Dutasteride—Urticaria—Sorafenib—kidney cancer	0.000519	0.00412	CcSEcCtD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	0.000516	0.00889	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	0.000516	0.00889	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—PDHB—kidney cancer	0.000514	0.00886	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—PDHB—kidney cancer	0.000514	0.00886	CbGpPWpGaD
Dutasteride—Pruritus—Erlotinib—kidney cancer	0.000513	0.00407	CcSEcCtD
Dutasteride—CYP3A5—Tamoxifen metabolism—CYP1A1—kidney cancer	0.000504	0.00869	CbGpPWpGaD
Dutasteride—Dizziness—Vinblastine—kidney cancer	0.000499	0.00396	CcSEcCtD
Dutasteride—Dizziness—Everolimus—kidney cancer	0.000497	0.00395	CcSEcCtD
Dutasteride—CYP3A5—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	0.000497	0.00857	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—CCBL1—kidney cancer	0.000483	0.00833	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—CCBL1—kidney cancer	0.000483	0.00833	CbGpPWpGaD
Dutasteride—CYP3A5—Biological oxidations—ACY1—kidney cancer	0.000482	0.00831	CbGpPWpGaD
Dutasteride—Hypersensitivity—Sorafenib—kidney cancer	0.000481	0.00382	CcSEcCtD
Dutasteride—Dizziness—Erlotinib—kidney cancer	0.00048	0.00381	CcSEcCtD
Dutasteride—Rash—Everolimus—kidney cancer	0.000474	0.00376	CcSEcCtD
Dutasteride—Dermatitis—Everolimus—kidney cancer	0.000474	0.00376	CcSEcCtD
Dutasteride—Angioedema—Paclitaxel—kidney cancer	0.000472	0.00375	CcSEcCtD
Dutasteride—CYP3A4—Irinotecan Pathway—BCHE—kidney cancer	0.000468	0.00806	CbGpPWpGaD
Dutasteride—Cardiac failure—Doxorubicin—kidney cancer	0.000465	0.00369	CcSEcCtD
Dutasteride—Hypersensitivity—Sunitinib—kidney cancer	0.000463	0.00367	CcSEcCtD
Dutasteride—Pruritus—Sorafenib—kidney cancer	0.000462	0.00366	CcSEcCtD
Dutasteride—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—kidney cancer	0.000461	0.00795	CbGpPWpGaD
Dutasteride—Rash—Erlotinib—kidney cancer	0.000458	0.00363	CcSEcCtD
Dutasteride—Dermatitis—Erlotinib—kidney cancer	0.000457	0.00363	CcSEcCtD
Dutasteride—Pruritus—Sunitinib—kidney cancer	0.000444	0.00353	CcSEcCtD
Dutasteride—Immune system disorder—Capecitabine—kidney cancer	0.00044	0.00349	CcSEcCtD
Dutasteride—Hypersensitivity—Dactinomycin—kidney cancer	0.000438	0.00348	CcSEcCtD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	0.000437	0.00753	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	0.000437	0.00753	CbGpPWpGaD
Dutasteride—Dizziness—Sorafenib—kidney cancer	0.000432	0.00343	CcSEcCtD
Dutasteride—Mental disorder—Capecitabine—kidney cancer	0.000427	0.00339	CcSEcCtD
Dutasteride—SRD5A1—Metabolism—GLIPR1—kidney cancer	0.000419	0.00722	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—PPAT—kidney cancer	0.000419	0.00722	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—PPAT—kidney cancer	0.000419	0.00722	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—GLIPR1—kidney cancer	0.000419	0.00722	CbGpPWpGaD
Dutasteride—Dizziness—Sunitinib—kidney cancer	0.000415	0.0033	CcSEcCtD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	0.000414	0.00713	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	0.000414	0.00713	CbGpPWpGaD
Dutasteride—Rash—Sorafenib—kidney cancer	0.000412	0.00327	CcSEcCtD
Dutasteride—Dermatitis—Sorafenib—kidney cancer	0.000411	0.00326	CcSEcCtD
Dutasteride—Breast disorder—Doxorubicin—kidney cancer	0.00041	0.00326	CcSEcCtD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	0.00041	0.00706	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	0.00041	0.00706	CbGpPWpGaD
Dutasteride—Rash—Sunitinib—kidney cancer	0.000396	0.00314	CcSEcCtD
Dutasteride—Dermatitis—Sunitinib—kidney cancer	0.000396	0.00314	CcSEcCtD
Dutasteride—Hypersensitivity—Vincristine—kidney cancer	0.000391	0.00311	CcSEcCtD
Dutasteride—CYP3A5—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	0.000391	0.00674	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—FH—kidney cancer	0.00039	0.00671	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—FH—kidney cancer	0.00039	0.00671	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—APRT—kidney cancer	0.00039	0.00671	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—APRT—kidney cancer	0.00039	0.00671	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	0.000381	0.00656	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	0.000381	0.00656	CbGpPWpGaD
Dutasteride—Rash—Dactinomycin—kidney cancer	0.000375	0.00298	CcSEcCtD
Dutasteride—SRD5A1—Metabolism—GPC3—kidney cancer	0.000366	0.00631	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—GPC3—kidney cancer	0.000366	0.00631	CbGpPWpGaD
Dutasteride—Pruritus—Gemcitabine—kidney cancer	0.000357	0.00283	CcSEcCtD
Dutasteride—SRD5A2—Metabolism—CA2—kidney cancer	0.000356	0.00614	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—CA2—kidney cancer	0.000356	0.00614	CbGpPWpGaD
Dutasteride—CYP3A4—Tryptophan metabolism—ALDH1A1—kidney cancer	0.000353	0.00608	CbGpPWpGaD
Dutasteride—Dizziness—Vincristine—kidney cancer	0.000351	0.00279	CcSEcCtD
Dutasteride—SRD5A1—Metabolism—ALAD—kidney cancer	0.000347	0.00598	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—ALAD—kidney cancer	0.000347	0.00598	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—ST3GAL2—kidney cancer	0.000339	0.00584	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—ST3GAL2—kidney cancer	0.000339	0.00584	CbGpPWpGaD
Dutasteride—Urticaria—Paclitaxel—kidney cancer	0.000335	0.00266	CcSEcCtD
Dutasteride—Rash—Vincristine—kidney cancer	0.000335	0.00266	CcSEcCtD
Dutasteride—Dermatitis—Vincristine—kidney cancer	0.000335	0.00266	CcSEcCtD
Dutasteride—SRD5A2—Metabolism—ALDH1A1—kidney cancer	0.000331	0.00571	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—ALDH1A1—kidney cancer	0.000331	0.00571	CbGpPWpGaD
Dutasteride—Rash—Gemcitabine—kidney cancer	0.000318	0.00252	CcSEcCtD
Dutasteride—SRD5A2—Metabolism—PGK1—kidney cancer	0.000318	0.00547	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—SLC5A3—kidney cancer	0.000318	0.00547	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—PGK1—kidney cancer	0.000318	0.00547	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—SLC5A3—kidney cancer	0.000318	0.00547	CbGpPWpGaD
Dutasteride—Dermatitis—Gemcitabine—kidney cancer	0.000318	0.00252	CcSEcCtD
Dutasteride—SRD5A2—Metabolism—LDHB—kidney cancer	0.000311	0.00537	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—LDHB—kidney cancer	0.000311	0.00537	CbGpPWpGaD
Dutasteride—Hypersensitivity—Paclitaxel—kidney cancer	0.000311	0.00247	CcSEcCtD
Dutasteride—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—kidney cancer	0.000301	0.0052	CbGpPWpGaD
Dutasteride—Pruritus—Paclitaxel—kidney cancer	0.000299	0.00237	CcSEcCtD
Dutasteride—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—kidney cancer	0.000291	0.00502	CbGpPWpGaD
Dutasteride—Immune system disorder—Doxorubicin—kidney cancer	0.000284	0.00225	CcSEcCtD
Dutasteride—CYP3A4—Estrogen metabolism—GSTM1—kidney cancer	0.00028	0.00482	CbGpPWpGaD
Dutasteride—Dizziness—Paclitaxel—kidney cancer	0.000279	0.00221	CcSEcCtD
Dutasteride—Mental disorder—Doxorubicin—kidney cancer	0.000275	0.00218	CcSEcCtD
Dutasteride—Urticaria—Capecitabine—kidney cancer	0.000275	0.00218	CcSEcCtD
Dutasteride—CYP3A5—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.000274	0.00472	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—CA9—kidney cancer	0.00027	0.00465	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—CA9—kidney cancer	0.00027	0.00465	CbGpPWpGaD
Dutasteride—Rash—Paclitaxel—kidney cancer	0.000266	0.00211	CcSEcCtD
Dutasteride—Dermatitis—Paclitaxel—kidney cancer	0.000266	0.00211	CcSEcCtD
Dutasteride—CYP3A4—Estrogen metabolism—CYP1A1—kidney cancer	0.000265	0.00457	CbGpPWpGaD
Dutasteride—CYP3A5—Biological oxidations—ALDH1A1—kidney cancer	0.000264	0.00455	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	0.000264	0.00455	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	0.000264	0.00455	CbGpPWpGaD
Dutasteride—Hypersensitivity—Capecitabine—kidney cancer	0.000255	0.00202	CcSEcCtD
Dutasteride—CYP3A4—Irinotecan Pathway—APC—kidney cancer	0.000254	0.00437	CbGpPWpGaD
Dutasteride—Pruritus—Capecitabine—kidney cancer	0.000245	0.00194	CcSEcCtD
Dutasteride—CYP3A4—Xenobiotics—CYP1A1—kidney cancer	0.000244	0.0042	CbGpPWpGaD
Dutasteride—CYP3A5—nephron tubule—kidney cancer	0.000239	0.0595	CbGeAlD
Dutasteride—CYP3A4—Tamoxifen metabolism—CYP1A1—kidney cancer	0.000234	0.00404	CbGpPWpGaD
Dutasteride—CYP3A4—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	0.000231	0.00398	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—CRABP1—kidney cancer	0.00023	0.00396	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—CRABP1—kidney cancer	0.00023	0.00396	CbGpPWpGaD
Dutasteride—Dizziness—Capecitabine—kidney cancer	0.000229	0.00182	CcSEcCtD
Dutasteride—CYP3A4—Biological oxidations—ACY1—kidney cancer	0.000224	0.00386	CbGpPWpGaD
Dutasteride—Rash—Capecitabine—kidney cancer	0.000218	0.00173	CcSEcCtD
Dutasteride—Dermatitis—Capecitabine—kidney cancer	0.000218	0.00173	CcSEcCtD
Dutasteride—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.000218	0.00375	CbGpPWpGaD
Dutasteride—CYP3A5—renal system—kidney cancer	0.000217	0.0541	CbGeAlD
Dutasteride—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.000215	0.0037	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—ITPR2—kidney cancer	0.000213	0.00368	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—ITPR2—kidney cancer	0.000213	0.00368	CbGpPWpGaD
Dutasteride—CYP3A5—kidney—kidney cancer	0.00021	0.0523	CbGeAlD
Dutasteride—CYP3A5—cortex of kidney—kidney cancer	0.000205	0.0509	CbGeAlD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	0.000197	0.00339	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	0.000197	0.00339	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—GSTT1—kidney cancer	0.000195	0.00336	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—GSTT1—kidney cancer	0.000195	0.00336	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—ACHE—kidney cancer	0.000195	0.00336	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—ACHE—kidney cancer	0.000195	0.00336	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—SCARB1—kidney cancer	0.000184	0.00318	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—SCARB1—kidney cancer	0.000184	0.00318	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—PTGS1—kidney cancer	0.000182	0.00314	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—PTGS1—kidney cancer	0.000182	0.00314	CbGpPWpGaD
Dutasteride—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	0.000182	0.00313	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—PSMD7—kidney cancer	0.000179	0.00308	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—PSMD7—kidney cancer	0.000179	0.00308	CbGpPWpGaD
Dutasteride—Urticaria—Doxorubicin—kidney cancer	0.000177	0.00141	CcSEcCtD
Dutasteride—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.000176	0.00304	CbGpPWpGaD
Dutasteride—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	0.000173	0.00298	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—BCHE—kidney cancer	0.00017	0.00292	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—BCHE—kidney cancer	0.00017	0.00292	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—SLC5A5—kidney cancer	0.000168	0.00289	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—SLC5A5—kidney cancer	0.000168	0.00289	CbGpPWpGaD
Dutasteride—Hypersensitivity—Doxorubicin—kidney cancer	0.000164	0.00131	CcSEcCtD
Dutasteride—CYP3A4—renal system—kidney cancer	0.000163	0.0406	CbGeAlD
Dutasteride—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	0.000162	0.0028	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—SLC2A1—kidney cancer	0.000162	0.00279	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—SLC2A1—kidney cancer	0.000162	0.00279	CbGpPWpGaD
Dutasteride—Pruritus—Doxorubicin—kidney cancer	0.000158	0.00125	CcSEcCtD
Dutasteride—CYP3A4—kidney—kidney cancer	0.000158	0.0392	CbGeAlD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	0.000157	0.00271	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	0.000157	0.00271	CbGpPWpGaD
Dutasteride—CYP3A5—Biological oxidations—GSTT1—kidney cancer	0.000155	0.00267	CbGpPWpGaD
Dutasteride—Dizziness—Doxorubicin—kidney cancer	0.000148	0.00117	CcSEcCtD
Dutasteride—CYP3A5—Biological oxidations—PTGS1—kidney cancer	0.000145	0.00251	CbGpPWpGaD
Dutasteride—Rash—Doxorubicin—kidney cancer	0.000141	0.00112	CcSEcCtD
Dutasteride—Dermatitis—Doxorubicin—kidney cancer	0.000141	0.00112	CcSEcCtD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	0.000137	0.00236	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	0.000137	0.00236	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—GSTP1—kidney cancer	0.000135	0.00233	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—GSTP1—kidney cancer	0.000135	0.00233	CbGpPWpGaD
Dutasteride—CYP3A5—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.000132	0.00227	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—ABCB1—kidney cancer	0.000128	0.0022	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—ABCB1—kidney cancer	0.000128	0.0022	CbGpPWpGaD
Dutasteride—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.000127	0.00219	CbGpPWpGaD
Dutasteride—CYP3A4—Tryptophan metabolism—CYP1A1—kidney cancer	0.000125	0.00216	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—GSTM1—kidney cancer	0.000124	0.00214	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—GSTM1—kidney cancer	0.000124	0.00214	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—ALDH1A1—kidney cancer	0.000123	0.00212	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—CYP1A1—kidney cancer	0.000118	0.00203	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—CYP1A1—kidney cancer	0.000118	0.00203	CbGpPWpGaD
Dutasteride—CYP3A5—Biological oxidations—GSTP1—kidney cancer	0.000108	0.00185	CbGpPWpGaD
Dutasteride—CYP3A5—Metapathway biotransformation—GSTP1—kidney cancer	0.000106	0.00183	CbGpPWpGaD
Dutasteride—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.000101	0.00174	CbGpPWpGaD
Dutasteride—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	9.98e-05	0.00172	CbGpPWpGaD
Dutasteride—CYP3A5—Biological oxidations—GSTM1—kidney cancer	9.88e-05	0.0017	CbGpPWpGaD
Dutasteride—CYP3A5—Metapathway biotransformation—GSTM1—kidney cancer	9.75e-05	0.00168	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	9.66e-05	0.00166	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	9.66e-05	0.00166	CbGpPWpGaD
Dutasteride—CYP3A5—Biological oxidations—CYP1A1—kidney cancer	9.37e-05	0.00161	CbGpPWpGaD
Dutasteride—CYP3A5—Metapathway biotransformation—CYP1A1—kidney cancer	9.24e-05	0.00159	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—POMC—kidney cancer	8.76e-05	0.00151	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—POMC—kidney cancer	8.76e-05	0.00151	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ACY1—kidney cancer	8.24e-05	0.00142	CbGpPWpGaD
Dutasteride—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	8.2e-05	0.00141	CbGpPWpGaD
Dutasteride—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	7.54e-05	0.0013	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—GSTT1—kidney cancer	7.21e-05	0.00124	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PDHB—kidney cancer	7.01e-05	0.00121	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—PTGS2—kidney cancer	6.99e-05	0.0012	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—PTGS2—kidney cancer	6.99e-05	0.0012	CbGpPWpGaD
Dutasteride—CYP3A5—Biological oxidations—POMC—kidney cancer	6.99e-05	0.0012	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—PTGS1—kidney cancer	6.76e-05	0.00117	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—CCBL1—kidney cancer	6.59e-05	0.00114	CbGpPWpGaD
Dutasteride—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	6.11e-05	0.00105	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—PTEN—kidney cancer	6.1e-05	0.00105	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—PTEN—kidney cancer	6.1e-05	0.00105	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PPAT—kidney cancer	5.71e-05	0.000985	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—GLIPR1—kidney cancer	5.71e-05	0.000985	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—FH—kidney cancer	5.31e-05	0.000915	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—APRT—kidney cancer	5.31e-05	0.000915	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—GSTP1—kidney cancer	5e-05	0.000862	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—GPC3—kidney cancer	4.99e-05	0.000861	CbGpPWpGaD
Dutasteride—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	4.93e-05	0.00085	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—CA2—kidney cancer	4.86e-05	0.000837	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ALAD—kidney cancer	4.73e-05	0.000816	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ST3GAL2—kidney cancer	4.62e-05	0.000796	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—GSTM1—kidney cancer	4.6e-05	0.000792	CbGpPWpGaD
Dutasteride—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	4.53e-05	0.000781	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ALDH1A1—kidney cancer	4.52e-05	0.000778	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	4.36e-05	0.000751	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—SLC5A3—kidney cancer	4.33e-05	0.000746	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PGK1—kidney cancer	4.33e-05	0.000746	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—PIK3CA—kidney cancer	4.3e-05	0.000741	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—PIK3CA—kidney cancer	4.3e-05	0.000741	CbGpPWpGaD
Dutasteride—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	4.3e-05	0.00074	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—LDHB—kidney cancer	4.25e-05	0.000732	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ACY1—kidney cancer	3.83e-05	0.00066	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—CA9—kidney cancer	3.68e-05	0.000634	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PDHB—kidney cancer	3.26e-05	0.000562	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—POMC—kidney cancer	3.25e-05	0.00056	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—CRABP1—kidney cancer	3.13e-05	0.000539	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—CCBL1—kidney cancer	3.06e-05	0.000528	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ITPR2—kidney cancer	2.91e-05	0.000502	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PPAT—kidney cancer	2.66e-05	0.000458	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—GLIPR1—kidney cancer	2.66e-05	0.000458	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ACHE—kidney cancer	2.65e-05	0.000457	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—GSTT1—kidney cancer	2.65e-05	0.000457	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—SCARB1—kidney cancer	2.51e-05	0.000433	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PTGS1—kidney cancer	2.49e-05	0.000429	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—FH—kidney cancer	2.47e-05	0.000426	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—APRT—kidney cancer	2.47e-05	0.000426	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PSMD7—kidney cancer	2.44e-05	0.00042	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—GPC3—kidney cancer	2.32e-05	0.0004	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—BCHE—kidney cancer	2.31e-05	0.000398	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—SLC5A5—kidney cancer	2.28e-05	0.000394	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—CA2—kidney cancer	2.26e-05	0.000389	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—SLC2A1—kidney cancer	2.21e-05	0.00038	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ALAD—kidney cancer	2.2e-05	0.000379	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ST3GAL2—kidney cancer	2.15e-05	0.00037	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ALDH1A1—kidney cancer	2.1e-05	0.000362	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PGK1—kidney cancer	2.01e-05	0.000347	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—SLC5A3—kidney cancer	2.01e-05	0.000347	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—LDHB—kidney cancer	1.97e-05	0.00034	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—GSTP1—kidney cancer	1.84e-05	0.000317	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ABCB1—kidney cancer	1.74e-05	0.0003	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—CA9—kidney cancer	1.71e-05	0.000295	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—GSTM1—kidney cancer	1.69e-05	0.000291	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—CYP1A1—kidney cancer	1.6e-05	0.000276	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—CRABP1—kidney cancer	1.46e-05	0.000251	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ITPR2—kidney cancer	1.35e-05	0.000233	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—GSTT1—kidney cancer	1.23e-05	0.000213	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ACHE—kidney cancer	1.23e-05	0.000213	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—POMC—kidney cancer	1.19e-05	0.000206	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—SCARB1—kidney cancer	1.17e-05	0.000201	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PTGS1—kidney cancer	1.16e-05	0.000199	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PSMD7—kidney cancer	1.13e-05	0.000195	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—BCHE—kidney cancer	1.07e-05	0.000185	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—SLC5A5—kidney cancer	1.06e-05	0.000183	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—SLC2A1—kidney cancer	1.03e-05	0.000177	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PTGS2—kidney cancer	9.53e-06	0.000164	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—GSTP1—kidney cancer	8.55e-06	0.000147	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PTEN—kidney cancer	8.31e-06	0.000143	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ABCB1—kidney cancer	8.09e-06	0.00014	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—GSTM1—kidney cancer	7.86e-06	0.000135	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—CYP1A1—kidney cancer	7.45e-06	0.000128	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PIK3CA—kidney cancer	5.86e-06	0.000101	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—POMC—kidney cancer	5.55e-06	9.57e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PTGS2—kidney cancer	4.43e-06	7.64e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PTEN—kidney cancer	3.86e-06	6.66e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PIK3CA—kidney cancer	2.73e-06	4.7e-05	CbGpPWpGaD
